Android app Apple app link

Denali Therapeutics Inc. (DNLI) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$20.17
Day's range
$21.75

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
07/13/2026 Wedbush Laura Chico $26.00 $25.33   2.63%
06/22/2026 Stifel Nicolaus Paul Mattels $41.00 $23.76   72.54%
05/08/2026 Wedbush Laura Chico $23.00 $20.11   14.37%
03/02/2026 Jefferies Andrew Tsai $40.00 $21.00   90.48%
01/08/2026 Morgan Stanley Sean Laaman $40.00 $16.95   135.99%
01/07/2026 UBS Michael Yee $25.00 $17.21   45.26%
12/11/2025 Wedbush Laura Chico $30.00 $17.61   70.36%
12/05/2025 Wedbush Laura Chico $31.00 $20.11   54.15%
11/17/2025 Stifel Nicolaus Paul Mattels $37.00 $17.67   109.39%
01/07/2025 BTIG Thomas Shrader $32.00 $21.18   51.09%
11/01/2024 Jefferies Michael Yee $45.00 $27.05   66.36%
10/14/2024 BTIG Thomas Shrader $35.00 $28.00   25%
09/04/2024 Bank of America Securities Tazeen Ahmad $29.00 $25.12   15.45%
09/03/2024 B.Riley Financial Marank Mamtani $33.00 $25.12   31.37%
09/03/2024 Goldman Sachs Salveen Richter $46.00 $25.12   83.12%
09/03/2024 Stifel Nicolaus Paul Mattels $22.00 $25.12   -12.42%
08/04/2021 Goldman Sachs Salveen Richter $112.00 $52.93   111.6%
05/17/2021 UBS Esther Rajavelu $70.00 $55.51   26.1%

Denali Therapeutics Inc FAQ's

Denali Therapeutics Inc has been rated by research analysts at UBS, Robert W. Baird, Morgan Stanley, Wedbush, Stifel Nicolaus, Deutsche Bank in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.